Determination of CA 19-9 and CA 15-3 on Elecsys® 2010 immunoanalyzers -: Results of a field study.

被引：0
|
作者：
Domke, I
Stieber, P
van Helden, J
Friese, S
van Kamp, GJ
Roth, HJ
Troalen, F
Weisbrich, C
Wollenberg, P
机构：
[1] Roche Diagnost GmbH, Mannheim, Germany
[2] Univ Munich, Klinikum Grosshadern, Inst Klin Chem, D-8000 Munich, Germany
[3] Labor Dr Stein, Moenchengladbach, Germany
[4] MEDTRAC Laborbetriebsgesesll mbH, Poing, Germany
[5] Acad Hosp VU, Amsterdam, Netherlands
[6] Labor Dr Limbach & Kollegen, Heidelberg, Germany
[7] Inst Gustave Roussy, Villequif, France
[8] Inst Klin Chem Pathobiochem, Leipzig, Germany
[9] Labor Dr Kramer, Geesthacht, Germany
来源：
CLINICAL CHEMISTRY | 1999年 / 45卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A109 / A109
页数：1
相关论文
共 50 条
  • [41] Development of microplate assays for CA 19-9 and CA 15-3 using mucin tumor markers isolated from ovarian cyst fluid and breast tumor cytosol.
    Wang, T
    Wu, JT
    CLINICAL CHEMISTRY, 1996, 42 (06) : 711 - 711
  • [42] Determination of CA 125 on the Elecsys 2010 analyzer - Results from the multicenter evaluation.
    Domke, I
    Chan, DW
    Hubl, W
    vanIngen, HE
    vanToorenenbergen, AW
    Rymer, JC
    Bagnard, G
    Geiger, T
    CLINICAL CHEMISTRY, 1997, 43 : 650 - 650
  • [43] Serum determination of CA 19-9 in diagnosing pancreatic cancer: An obituary
    Pezzilli, R.
    Casadei, R.
    Calculli, L.
    Santini, D.
    Morselli-Labate, A. M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (01) : 73 - 74
  • [44] VALUE OF CA 15-3 DETERMINATION IN THE DIAGNOSIS OF MALIGNANT PLEURAL SHEDDINGS
    ROMERO, S
    HERNANDEZ, L
    SALAR, A
    GARCIASEVILA, R
    ESPASA, MA
    MARTINSERRANO, C
    REVISTA CLINICA ESPANOLA, 1992, 190 (07): : 339 - 343
  • [45] Determination of CA 72-4, CA 19-9 and CEA in the diagnosis of stomach cancer.
    Hoang, VS
    Dao, KC
    Do, DV
    Hoang, TH
    Nguyen, SH
    Nguyen, QB
    CLINICAL CHEMISTRY, 1998, 44 : A41 - A41
  • [46] The Efficacy of Serum Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA125), Carbohydrate Antigen 19-9 (CA19-9), Carbohydrate Antigen 15-3 (CA15-3), α-Fetoprotein (AFP) and Human Chorionic Gonadotropin (hCG) Levels in Determining the Malignancy of Solitary Pulmonary Nodules
    Bekci, T. T.
    Senol, T.
    Maden, E.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (02) : 438 - 445
  • [47] Assessment of average of normals (AON) procedure for outlier-free datasets including qualitative values below limit of detection (LoD): an application within tumor markers such as CA 15-3, CA 125, and CA 19-9
    Usta, Murat
    Aral, Hale
    Mete Cilingirturk, Ahmet
    Kural, Alev
    Topac, Ibrahim
    Semerci, Tuna
    Koseoglu, Mehmet Hicri
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 (07): : 553 - 560
  • [48] CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer
    Karachristos, A
    Scarmeas, N
    Hoffman, JP
    JOURNAL OF GASTROINTESTINAL SURGERY, 2005, 9 (09) : 1286 - 1292
  • [49] COMPETITIVE-INHIBITION IMMUNOASSAY FOR THE DETERMINATION OF SIALOSYL LEWIS (CA 19-9)
    SKOCZENSKI, BA
    TURNER, CJ
    JETTE, D
    VANHEEL, A
    SURESH, MR
    CLINICAL CHEMISTRY, 1988, 34 (06) : 1293 - 1293
  • [50] Determination of CA 19-9 antigen by homogeneous immunoassay on the BN II.
    Schmidt, B
    Janzen, R
    Harthus, HP
    CLINICAL CHEMISTRY, 1997, 43 : 556 - 556
12345